wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55280895-E77A51FA-B4DF-4026-9112-0847F4DB5A40
Q55280895-E77A51FA-B4DF-4026-9112-0847F4DB5A40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55280895-E77A51FA-B4DF-4026-9112-0847F4DB5A40
Potent anti-leukemic activity of a specific cyclin-dependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemia.
P2860
Q55280895-E77A51FA-B4DF-4026-9112-0847F4DB5A40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55280895-E77A51FA-B4DF-4026-9112-0847F4DB5A40
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bd0ffc1e5d29c54fa7235745377d3da6b925c6f1
P2860
Final results of EFC6663: a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia.